Jun 25 |
Amylyx Pharmaceuticals: Potential To Redeem Itself With Data Readouts And Possible GLP-1 Acquisition
|
Jun 22 |
Amylyx inks deal to buy Eiger’s GLP-1 targeting drug
|
Jun 4 |
Amylyx Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
|
May 10 |
Amylyx Pharmaceuticals Reports Q1 2024 Financial Results
|
May 10 |
Breaking Down Amylyx Pharma: 9 Analysts Share Their Views
|
May 10 |
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q1 2024 Earnings Call Transcript
|
May 9 |
Amylyx Pharmaceuticals, Inc. (AMLX) Q1 2024 Earnings Call Transcript
|
May 9 |
Amylyx Pharmaceuticals, Inc. (AMLX) Reports Q1 Loss, Lags Revenue Estimates
|
May 9 |
Amylyx Pharmaceuticals GAAP EPS of -$1.75 misses by $1.76, revenue of $88.64M misses by $9.71M
|
May 9 |
Amylyx Pharmaceuticals Reports First Quarter 2024 Financial Results
|